Complete Autoimmune Workup for Muscle Weakness
For a patient presenting with muscle weakness, the autoimmune workup should include muscle enzyme testing (CK, aldolase, AST, ALT, LDH), inflammatory markers (ESR, CRP), troponin for cardiac involvement, autoimmune myositis antibody panel, and autoantibodies for myasthenia gravis (anti-AChR and antistriational antibodies). 1, 2
Essential Laboratory Testing
Muscle Inflammation Markers
- Creatine kinase (CK) - the primary marker for muscle inflammation, often markedly elevated in myositis 1, 3
- Aldolase - can be elevated even when CK is normal, making it critical for diagnosis 2
- Transaminases (AST, ALT) - frequently elevated in muscle inflammation 1
- Lactate dehydrogenase (LDH) - additional marker that can be elevated 1
Inflammatory Markers
Cardiac Evaluation
- Troponin - mandatory to evaluate for potentially life-threatening myocardial involvement 1, 2
- ECG and echocardiogram - if any clinical suspicion of cardiac involvement exists 1, 2
Autoantibody Testing
Myositis-Specific Antibodies
- Autoimmune myositis panel - should be obtained for grade 2 or higher severity 1
- Paraneoplastic autoantibody testing - including anti-TIF1γ, anti-NXP2, and other myositis autoantibodies, especially if muscle symptoms preceded any treatment 1
Myasthenia Gravis Antibodies
- Anti-acetylcholine receptor (anti-AChR) antibodies - to evaluate possible concomitant myasthenia gravis 1
- Antistriational antibodies - additional testing for myasthenia gravis overlap 1
Additional Testing
- Urinalysis - to screen for rhabdomyolysis 1
Clinical Examination Components
Neurologic Assessment
- Muscle strength testing - focusing on proximal muscle groups, as weakness (not pain) is more typical of myositis 1, 2
- Pattern of weakness - proximal extremity weakness suggests myositis, while distal weakness may indicate other conditions 4
Dermatologic Examination
- Skin findings - examine for Gottron's papules, heliotrope rash, V-sign, shawl sign, and cutaneous ulcers suggestive of dermatomyositis 2, 3
Systemic Assessment
- Dysphagia and respiratory muscle involvement - indicates more severe disease requiring urgent intervention 2
Advanced Diagnostic Testing (When Diagnosis Uncertain)
Imaging Studies
- MRI of proximal limbs - can reveal inflammatory changes even when muscle enzymes are normal, more sensitive than ultrasound 1, 2
Electrophysiologic Testing
- Electromyography (EMG) - may demonstrate myopathic changes or muscle fibrillations despite normal CK levels 1, 2
Tissue Diagnosis
- Muscle biopsy - should be considered when diagnosis is uncertain, can show inflammatory myopathy even with normal CK 1, 2
Critical Pitfalls to Avoid
Do not assume normal CK rules out myositis - aldolase, LDH, AST, and ALT can be elevated when CK is normal 2. This is a common diagnostic error that delays treatment.
Always check troponin and cardiac testing - myocardial involvement can be fatal and requires permanent discontinuation of causative agents 1, 2. Patients with concomitant myocarditis and myasthenia gravis have particularly high mortality rates 1.
Consider statin-induced autoimmune myopathy - in patients on statins who fail to respond to conservative management, test for anti-HMG CoA reductase antibodies 5, 6. This condition requires immunosuppressive therapy, not just statin discontinuation.
Screen for malignancy - given the paraneoplastic association with dermatomyositis, age-appropriate cancer screening is necessary 2.
Monitoring Parameters
Once diagnosis is established, serial monitoring should include: